Company profile
Blueberries Medical Corp.
OTC: BBRRF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, Reports USD
#997 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
32DFH 29DQ —GM 42SS 32
v0.1 · 45/100 weight · provisional
↑ balance-sheet leverage, disclosure history · ↓ return on equity, workforce scale
Methodology →Revenue TTM
$199.7k
Rev growth YoY (TTM)
-36.6%
Net income (FY)
-$1.2M
Employees
5
as of 2026-09-01
Market cap
$6.5M
as of 2026-09-01
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$223.2k312.0k CAD2025
Net income-$1.2M-1.7M CAD2025
Operating income-$985.6k-1.4M CAD2025
Total assets$495.5k679.1k CAD2025
Liabilities$261.3k358.2k CAD2025
Equity$234.1k320.9k CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Blueberries Medical Corp.’s revenue?
Blueberries Medical Corp. booked $223.2k in FY2025 revenue, contracting 35% year over year — slower than 77% of Healthcare companies we track, at a -533.4% net margin.
Peers · Healthcare
Sproutly Canada Inc.——Geron Corporation50DRegen BioPharma, Inc.35DHAVN Life Sciences Inc.——Brain Scientific Inc.——Anixa Biosciences, Inc.52DKey facts
CEOFacundo Garreton
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, null
ExchangeOTC: BBRRF
Employees5
IPO date2019-02-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.